Risks and benefits of long-term hormone replacement therapy

American Journal of Health-System Pharmacy

Volumn 60, Issue 14, 2003, Pages 1419-1425

  Biscup, Paula ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dosage schedules; Estrogens; Menopause; Osteoporosis; Toxicity

Indexed keywords

ESTROGEN;

CARDIOVASCULAR DISEASE; CONTROLLED STUDY; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MENOPAUSAL SYNDROME; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; ADULT; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ESTROGEN THERAPY; FEMALE; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0142089737     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.14.1419     Document Type: Review

References (18)

1. American Heart Association. 2002 Heart and stroke statistical update, www. americanheart.org/downloadable/heart/10148328094661013190990123HS_State_ 02.pdf (accessed 2002 Nov4).
2. American Heart Association. Women and coronary heart disease, www. americanheart.org/presenter.jhtml? identifier=2859 (accessed 2002 Nov 4).
3. National Cancer Institute. Questions and answers: use of hormones after menopause. http://newscenter.cancer.gov/pressreleases/estrogenplus.html (accessed 2002 Jul 16).
4. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative controlled trial (WHI). JAMA. 2002; 288:321-33.
5. Micromedex healthcare series. Vol. 113. Greenwood Village, CO: Micromedex; 1974-2002.
6. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: quantitative assessment of the epidemiologic evidence. Prev Med. 1991; 20:47-63.
7. International position paper on women's health and menopause: a comprehensive approach. Chap. 13. In: Best clinical practices. Bethesda, MD: National Heart, Lung, and Blood Institute; 2002:6-7.
8. Kakar F, Weiss NS, Strite SA. Noncontraceptive estrogen use and risk of gallstone disease in women. Am J Public Health. 1988; 78:564.
9. Castellsague J, Perez Gutthann S, Garcia Rodriguez LA. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review. Drug Saf. 1998; 18:117-23.
10. Benichou J, Gau MH, Mulvihill JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol. 1996; 14:103-10.
11. Grodstein F, Manson JE, Colditz GA et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000; 133:933-41.
12. Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study: a prospective, observational study. Ann Intern Med. 2001; 135:1-8.
13. Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA. 1995; 273:199-208.
14. Herrington DM, Reboussin DM, Brosnihan KB et al. Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis. N Engl J Med. 2000; 343:522-9.
15. Hulley S, Grady D, Bush T et al. Randomization trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS). JAMA. 1998; 280:605-13.
16. Grady D, Herrington D, Bittner V et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA. 2002; 288:49-57.
17. Hulley S, Gurberg C, Barrett-Connor E et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement study follow-up (HERS II). JAMA. 2002; 288:58-66.
18. Postmenopausal hormone therapy: facts about postmenopausal hormone therapy. www.nhlbi.nih.gov/health/women/pht_facts.htm (accessed 2002 Nov 4).